Publication | Closed Access

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial

Surgical OncologyNeoadjuvant ChemotherapyMedicineCancer ManagementGynecologyIv Ovarian CancerSurgeryPrimary SurgeryCancer TreatmentOncologyGynecology OncologyOvarian Cancer